#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of head and neck Neuroendocrine carcinoma metastatic Transferrin decreased Leukoencephalopathy Myxoid liposarcoma Alpha-1 antitrypsin deficiency Polycythaemia vera Gastroenteropancreatic neuroendocrine tumour disease Vulval cancer recurrent Angiosarcoma Postprandial hypoglycaemia Lymphatic malformation Eosinophilic granulomatosis with polyangiitis Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Mantle cell lymphoma More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Trials in Disease Congenital generalised lipodystrophy – Life with Disease Lennox-Gastaut syndrome – Trials in Disease Von Willebrand’s disease – Treatment Waldenstrom’s macroglobulinaemia refractory – Life with Disease Alagille syndrome – Diagnostics Noonan syndrome – Treatment Netherton’s syndrome – Treatment Soft tissue sarcoma – Life with Disease Gastrointestinal stromal tumour – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Neflamapimod Leriglitazone Saruparib Oxybuprocaine Hydrochloride Dcc-3116 HYPOCHLOROUS ACID Futibatinib CANNABINOL FOSFOMYCIN CALCIUM Tigulixostat Betamethasone (-)-PHENSERINE TARTRATE Pirfenidone Imifoplatin Leuprorelin Acetate Metamizole Magnesium Hhalpc Promethazine Hydrochloride Op-1250 Thymalfasin More therapies…

    Learn about Your Condition

    VEXAS syndrome Post procedural complication Spinal cord injury cervical External cephalic version Myeloid leukaemia Bladder cancer stage II Acute respiratory failure Papilloma viral infection Arrhythmia supraventricular Schizophrenia Growth hormone deficiency Thrombectomy Anaemia Osteosarcoma Small for dates baby More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • ZAMPILIMAB
    Belgium Bulgaria Czechia France Germany Italy +5

  • A study to evaluate the effectiveness of ispaghula husk in patients with low anterior resection syndrome after rectal cancer surgery

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Low anterior resection syndrome
    Investigated Drugs:
    • ISPAGHULA HUSK
    Norway

  • Comparing cognitive behavioral therapy alone versus cognitive behavioral therapy combined with degarelix to prevent sexual offenses in patients with paraphilic disorders

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Compulsive sexual behaviour
    Investigated Drugs:
    • Degarelix
    Sweden

  • A study of pembrolizumab, belzutifan, and lenvatinib before main treatment in patients with localized kidney cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • Belzutifan
    • Lenvatinib
    • Pembrolizumab
    Spain

  • Study of dexmedetomidine and a drug combination for treating patients on mechanical ventilation with septic shock.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Hydrocortisone Acetate
    • Noradrenaline Tartrate
    France

  • A study of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Spain
Previous Page
1 … 717 718 719 720 721 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!